# ASNSD1

## Overview
ASNSD1 is a gene that encodes the protein asparagine synthetase domain containing 1, which plays a crucial role in amino acid metabolism, particularly in the synthesis of asparagine. This protein is categorized as a metabolic enzyme and is primarily active in the cytoplasm, where it contributes to cellular homeostasis and metabolic regulation. ASNSD1 is highly expressed in skeletal muscle, indicating its significant role in muscle function and metabolism (Vogel2020Progressive). Research involving Asnsd1-deficient mice has revealed its involvement in metabolic interactions between skeletal muscle and adipose tissue, with deficiencies leading to progressive degenerative myopathy and myosteatosis (Vogel2020Progressive). Additionally, ASNSD1 has been implicated in metabolic diseases such as type 2 diabetes mellitus, underscoring its importance in maintaining metabolic health (Vogel2020Progressive).

## Structure


## Function
The ASNSD1 gene encodes a protein that is involved in amino acid metabolism, specifically in the synthesis of asparagine, an amino acid crucial for protein synthesis and cellular function. The protein is thought to be active in the cytoplasm, where it contributes to cellular homeostasis and metabolic regulation (Vogel2020Progressive). In healthy human cells, ASNSD1 is expressed at maximal levels in skeletal muscle, suggesting a significant role in muscle function and metabolism (Vogel2020Progressive). 

Studies in Asnsd1-deficient mice have provided insights into the potential functions of this protein, indicating its involvement in metabolic interactions between skeletal muscle and adipose tissue. These mice develop a progressive degenerative myopathy characterized by muscle weakness, sarcopenia, and myosteatosis, where muscle tissue is replaced by adipose tissue. Despite these changes, there are no signs of lipotoxicity, suggesting a role for ASNSD1 in maintaining metabolic balance (Vogel2020Progressive). The protein's function in healthy cells may include regulating the balance between muscle and fat tissue, which is crucial for maintaining proper body composition and metabolic health (Vogel2020Progressive).

## Clinical Significance
Mutations in the ASNSD1 gene have been linked to progressive degenerative myopathy and myosteatosis, as observed in Asnsd1-deficient mice. These mice exhibit severe muscle weakness and increased body fat percentage, with muscle tissue being progressively replaced by adipose tissue. Despite these changes, there is no evidence of lipotoxicity, suggesting unique metabolic dysfunctions (Vogel2020Progressive). The condition in these mice mirrors aspects of human muscular dystrophies, such as Duchenne muscular dystrophy, where fat infiltration into muscle is a hallmark feature. However, the myopathy in Asnsd1-deficient mice is milder compared to Duchenne muscular dystrophy (Vogel2020Progressive).

ASNSD1 has also been identified as a candidate gene linked to type 2 diabetes mellitus, indicating its potential relevance in metabolic diseases (Vogel2020Progressive). The absence of ASNSD1 results in a unique myopathy with minimal fibrosis and sparing of type I fiber-dominant muscles, suggesting a specific role in muscle and liver metabolism (Vogel2020Progressive). These findings highlight the importance of ASNSD1 in maintaining normal muscle function and its potential involvement in metabolic disorders.


## References


[1. (Vogel2020Progressive) Peter Vogel, Zhi-Ming Ding, Robert Read, Christopher M. DaCosta, Melissa Hansard, Daniel L. Small, Gui-lan Ye, Gwenn Hansen, Robert Brommage, and David R. Powell. Progressive degenerative myopathy and myosteatosis in asnsd1-deficient mice. Veterinary Pathology, 57(5):723â€“735, July 2020. URL: http://dx.doi.org/10.1177/0300985820939251, doi:10.1177/0300985820939251. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1177/0300985820939251)